| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.056 | 0.07 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.07 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.08 |